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The Moolgavkar-Knudson theory ofc g of ipom the viable portionsof earier multiage theories
andpridesthebasisforboththe lin d mul and biogcly baseddow4 eponse
This thry begn With th pre that occurs because Ire sble genetic chans (mutations) are requrd for
trani fmio ofnmal cells to canc cels; inc data ar c ent with only twocrit changesbeingrequired,
buta smallcontributionfromthroe orhigher mutation pathyscannotberuledout. Eventsoragentsthatincreasethe
rateofceD division also increae the that oneofthesecritical wil occur byredudng the time available
for repair ofDNA lesions before mitosis. TheDNA lesions can occur frombackground causes orfromtreatment with
mutagenic agents Thus, theequationsdescribingincidence as a function ofexposuretocardnogenic agentsincludetwo
separateterms, oneaccountingfor mutagenic and oneformitogenic stimuli. Athigh exposurestheseinteract, produc-
ingsynergismandhighincidencerates, butat lowexposuresthey areeffectivelyindependent. The multis modelsthat
are now usedincludeonly termscorrespondingtothemutanstimuli andthusfail toadequately describe incidence
athighdoserates Biologicallybased modelsattempttoincludemitogeniceffects, aswell;they are usualy nUitedbydata
availability.
Introduction
Amidthecontroversythathasswirledaroundproceduresfor
extrapolating cancerhazardfunctionstoverysmallexposures,
therehasbeen afrequentassertionthattheprocedureshave no
scientific foundation. Implied in thatassertion is the idea that
procedureslackingsuchafoundationcannotserveauseful func-
tion in public health. This paper explores the foundations of
dose-response models.
Avarietyofmathematicalmodelshavebeenused(orproposed
to be used) over the last 15 years to draw inferences about the
hazard functionforcancerinexposuresfarbelowwhereadose-
responsecanbeobserved. They canbedividedintotwogroups:
those based on some tolerance distribution (probit, logit,
Weibull) andthosethatderive, onewayoranother, frommodels
fortheage-specificincidenceofcancer. Includedamongthelat-
terarethegamnua-multihitprocedure, thelinearized(LMS)pro-
cedure of Guess et al. (1), and the several recent procedures
sometimes calledbiologically based models (2-4).
"Biologically based models" carries a connotation that the
widely usedprobit, Weibull, and LMSprocedures arenotbas-
edonthebiology weknow. Thatclearly is not so. Whatis true
isthatthemorerecentproceduresarederivedfromamorenearly
completetheory-MoolgavkarandKnudson'stwo-eventtheory
ofcarcinogenesis (5)-and from a richer observational base.
Thus, they aremorelikelytobereliableoutsidetheobservable
range.
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Tolerance-Distribution Models
ItisnowgenerallyacceptedthattheprobitandWeibullmodels
andrelatedproceduresarephenomenologicallybased. Theysuc-
cessfully describe a broad range ofphenomena relevant to the
estimation ofacarcinogenhazard function. Probitand related
mathematicalmodelsdescribethedose-responsecurvesusually
observed in themedical sciences, whereas Weibull-type func-
tionsdescribemortality. Yet, itisalsorecognizedthatthereare
notunderlyingtheoreticalbases fortheseparticularfunctions.
Further, the data used to derive these models are not precise
enoughtopermitgoodtestsoftheirreliability, evenatincidences
inthe 1% range(W. J. Adamsetal.,unpublishedresults). Thus,
nostatementcanbemadeabouthowwelleachmightrepresent
reality when extrapolated to incidences well below the obser-
vable range (i.e., risks of 10-3 or smaller). Because the in-
cidencepredictedbytheprobitfunctiondeclines morerapidly
withdecreasingdosethanthatofanyothercommonlyusedfunc-
tion, it might be considered to represent a conceptual (not
statistical)lowerboundtotheextrapolatedfunction. Suchuseis
arbitrary.
Model-Free Procedures
Gaylor et al. (6) and Krewski et al. (7) have described very
similarprocedures forsetting exposurelimitsbasedonbioassay
data. The basis for these appears to be entirely pheno-
menological, although some theory must underlie their use
(if only the theory that response is some monotonically
increasing function of exposure). We would assert that theJ. D. WILSON
justification for choosing the linear-through-zero approach
follows fromthe samebiologicaltheory thatinspired the LMS
procedure (vide infra). However, to the extent that these pro-
cedures are believed to have no basis in theory, their use is
arbitrary.
Multi-Event Models and Procedures
The family of multi-event models includes a variety of
standard-settingproceduresandmathematicalmodels, including
the LMS and gamma-multihit procedures, the Armitage-Doll
model (8), andmodelsderivedbyMoolgavkarandKnudson(S)
and others (2-4,9). These have a long and honorable history
[described sometimeagobyWhittemoreandKeller(10)]. The
formulationwasdevelopedtodescribetheage-specificincidence
of adult cancers. If it is assumed that carcinogens behave as
chemical electrophiles, undergoingchemically first-order reac-
tions with DNA, thentheGuess etal. exponentialformulation
in dose (1) fills out naturally. However, out Moolgavkar (11)
pointed in 1979thattheArmitage-Dollmodeldoesnotfittheage-
specificincidencedataformostcancers,particularlythoseofthe
sexorgansandofchildhood. IfthevalidityoftheGuessetal. (1)
formulationdepended onthegeneralvalidity oftheArmitage-
Doll model, we would have to conclude that the use ofthese
models shouldbeabandoned. However, thatmodel canequal-
ly wellbederived fromthe moregeneralMoolgavkardescrip-
tionoftheincidencebymakingcertainassumptions. Thus, these
procedures canbevalidunder acertain setofconditions. What
follows is a briefdescriptionofthe theory ofcarcinogenesis as
it now stands, leading to adiscussionofthe limitationsofthese
simplifiedprocedures andthepossiblestrengthsandlimitations
of more complex models based on the Moolgavkar-Knudson
theory.
We will not discuss further the gamma-multihit model. Its
theoretical base is identical to that of the other multi-event
models. What distinguishes the gamma-multihit model is the
assumptionofaparticular function forthedose response. Ap-
parently, thisformwasassumedforthemodel'stractability, since
theresultingequations canbesolvedexactly. Thereseemstobe
no reason to believe thatthese equations adequately represent
reality.
Theory of Carcinogenesis
Cancer is now regarded as a disease of differentiation, by
whichis meantthatthecellsthatgrowintocancerdividewhen
they shouldundergodifferentiation. Geneticchange(alterations
heritable atthelevelofthecell) isrequired, butepigenetic risk
factors clearly are important as well. The chalones discussed
before 1980 (13) now are identified as the protein hormones
called "growth factors" (6,14). The critical genetic changes
somehowinvolvethesegrwthfactors. Yet,thefundamentalcon-
ceptsthatarethemodernequivalentsofgrowthfactors goback
halfa century ofmore.
In 1981, MoolgavkarandKnudson(5)describedthefirstsyn-
thesisofoldconceptsthatprovides asatisfactorytheoryofcar-
cinogenesis. A similartheory wasdescribed shortlythereafter
byGreenfieldetal. (2). Thetheoryisbuiltontwofundamental
concepts: Mutations occur when unrepaired DNA lesions are
presentatmitosis, and atleasttwomutations incriticalgenetic
loci are required to convert a phenotypically normal cell to a
cancerous cell.
Thistheory assumesthatcancers areclonal, thatthey do not
ordinarily startintissuesthatdonotincludecellscapableoffur-
therdivision, andthatmutant(cancerous)cellscancontinueto
mutateandthusevolvebothgenotypically andphenotypically.
This evolution confers survival advantages on the daughter
clones; itprovidesatthecellularlevelforthephenomenoncalled
"progression" by pathologists (15). Typically thisprogression
ends with the appearance of a clone capable of rampant
metastatic growth and the death of the host. Much has been
learnedinthepastdecadeaboutthenatureofthecriticallocithat
are altered to bring about cancer. These alterations affect the
systembywhichintercellularregulationofmitosisanddifferen-
tiationtakesplace. Thisknowledgeilluminatesandsolidifiesthe
basictheorypropoundedbyMoolgavkarandKnudson. Several
mathematical formulations of this theory have appeared
(4,9,16,17). A complete solution has been published that
recognizesthateach oftheprocessesis stochastic (12,16).
Thebiologicalmodelencodedbythesemathematicalformula-
tionscanbedescribedasfollows(2-5,15,18,19): Inatissuecon-
taining cells capable ofdivision (stemcells), normal cells can
eitherdivide,givingtwonormalstemcells, ordifferentiate, giv-
ingacellnotcapableoffurtherdivision. Ifanormalcellenters
mitosiswithanunrepairedlesionatsomecritical site, division
willyieldonenormalcellandonemutantcell. Suchmutantcells
are identified as initiated, borrowing terminology from ex-
perimentalcarcinogenesis. Recentresearchsuggeststhatthese
initiatedcellsresponddifferently fromnormalcellstothehor-
monesthataffectintercellulargrowth/differentiationregulation,
making themmorelikelytodivideandlesslikelytodifferentiate
atany hormoneconcentration.
Initiated cells otherwise behave similarly to normal cells,
dividing to give additional initiated cells, differentiating, or
dividingwithanotherunrepairedlesiontoyieldatwice-mutant
cell, now (probably)phenotypically cancerous. (Notethatthis
modeldescribesthemostfrequently followedpathwaybetween
normalcellsandcancer. Itimplicitlyincludesthepossibilitythat
more than two mutations can occur before the cancerous
phenotype emerges. Since mutation is a rare event, however,
suchpathwayswillberarelyobserved,justbecauseofthecon-
catenationoflowprobabilities.)
In Moolgavkar's original formulation (15,16), division, dif-
ferentiation, and mutation were taken as deterministic and
assignedratesa,(3, andIA, respectively. Normal cellsdivideat
rateal,differentiateatratefll,andmutateatrateiI; initiatedcells
divide at rate a2, etc. Now it is recognized that all these are
stochastic processes, andthe labels areassigned to the several
corresponding transitionprobabilities (2,3,12,16).
Thistheoryrecognizesthatcertaintreatments mayincreasethe
netbirth rates ofinitiatedcells. These lead to expansion ofthe
clone of initiated cells; again borrowing from experimental
cancer, theprocessistermed "promotion" (5,15). Becauseitis
recognized thatadventitious(backgroundorspontanes)initia-
tion occurs through the natural mutagenic flux, the theory
predictsthatpurepromoters(agentswithlittleornomutagenic
activity)willactascompletecarcinogensinordinarybioassays.
This suggests that the term "complete carcinogen" conveys
nothing andthatits use shouldbediscontinued.
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The theory ofcarcinogenesis rationalizes a large numberof
observations from experimental science, epidemiology, and
clinical practice (2-5,15). Inaddition, anumberofpredictions
made from the theory have been verified, particularly the
phenomenoncalled I-P-I(initiation-promotion-initiation) (13).
Thetheoryprovidesagoodexplanationfortheage-specific in-
cidences ofessentially all cancers (5,11), including the adult
cancerforwhichtheArmitage-Doll modelprovidedanearlier,
different explanation. The Armitage-Doll explanation is now
regarded as inadequate (20). Like Armitage-Doll, the current
theory is a member ofthe set ofmulti-event models, although
morespecificthanearlieronesinthatitgivesspecificidentifica-
tiontotheseveralevents. Thetheorydiffersfromearliertheories
intheexplicitplaceprovidedforeffectofincreasedmitoticrate
oncancerrisk. Boththevariouslinearextrapolationprocedures
and the more recent biologically based models canbe derived
from this theory.
Extrapolation Procedures: Linear
Models
Itisconvenienttodiscussderivationofthevariousprocedures,
their applicability, and their limitations in the context of
Moolgavkar's approxinatesolutiontotheage-specific incidence
(5,16).
l(t) X.LJ12 X(s) e(¶CX2Xt-S)dS
' ~~~~~~~~~(1)
HereX(s)denotesthenumberofnormal stemcells attimes,
it, andI2arethemutationratesofnorma andinitiat cels, and
(a2 - (32) isthenetbirthrateofinitiatedcells. [AsMoolgavkar
andDewanjipointedout(17), thisequationisvalidonly forI(t)
< 0.2; athigherincidenceamorenearlyexactformulationmust
beused.] Inthisformulation, thesynergisticeffectsofinitiated
cell mitotic rateonmutationprobability becomeapparent.
Eq. (1) assumes only adventitious initiation andno effectof
treatmentonany oftheotherparameters. Generalizing, taking
L =p + 1t,(d), where y0isthe adventitious rate, weobtain:
I(d,t) z [(Ojl.jd)](J.0.2d)l
Xf(d,s) e[O(,(d)OS(d)Xt-5)dS (2)
In other words, treatment is allowed to affect any or all ofthe
several parameters inthemodel.
Ifexperimentalconditionsaresuchthatwecanassumethein-
tegral termtobeconstantoveraseriesofexperimentscarriedto
constanttime t, then Eq. (3) results.
l(d) -- (AO+p(d)]lAo-A2(d)] (3)
Ifwefurtherassume t(d)tobelinear, asGuessetal. did(I), we
obtain:
(4)
Eq. (4) is the same astheapproximatesolutiontothemultistage
model ford < < givenbyGuessetal. (1);italsocouldprovide
arationale forproceduresproposedbyGaylor etal. (6) andby
Krewskietal. (7).
LimitationsofLinear Models
Two serious constraints exist forthe linear models. The ap-
proximation from which they can be derived is valid only for
relatively low values ofI, and there mustbe no significant in-
crease in themitotic rateofeither normal or initiated cells. In
fact, itappearsfromtherecentworkofCohenandEllwein(2,3)
thatthe firstcondition will usually bemet ifthe second one is
met. Theirworksuggeststhattreatmentconditionsthatincrease
mitotic ratecausetheincidence versus exposurecurve tobend
sharplyupward. Atpresent, weknowonlyoneexampleofanex-
perimentyielding atumor incidence inthe 20% to 30% range
wherethedoseresponseislinear, viz., thelivertumorsinmice
treatedwith2-AAFintheEDO1 study(21). AccordingtoCohen
andEllwein's recentanalysis (21), noevidenceforamitoticrate
increase is seen. Otherwise, sofar, wheneverrelevantevidence
isavailable, highincidenceseemstobeaccompaniedbymitotic
rateincrease (15). (Notethatonly afew well-characterized ex-
amples areyetavailable.)
Theimportanceofthismitoticrateincreaseisquiteclear. Ap-
plicationoflinearmodelstohighdose-ratedatagivinghighin-
cidence is notappropriate. Toapply linearmodelsunderthose
circumstances will greatlyexaggeratetheestimated incidence.
Itisespeciallyinappropriatetoapplytheseprocedureswithdata
setsfromtreatmentwithnongenotoxiccompounds. However, it
maybeappropriatetousethesemethodsforstronglygenotoxic
compounds,whenthedatashownoevidenceforcurvalinearity.
Itisalsoclearthatweneedtoinvestigate furtherthebehaviorof
mitoticrateundertreatnentwithmitogens sothatwecanbegin
toaddress thedeficienciesinthese linearmethods.
Biologically Based Models
Thorslund et al. (4) coined the phrase "biologically based
nwdels" todescribethefamilyofmodelstheyhaveexplored. Im-
plied by the phrase is a notion that other models are not
biologically based and thus somehow inferior. This is not
necessarily thethecase. Thorslund's model structures, inpar-
ticular, sufferfromaninabilitytoincorporatetime-dependence
ofcell number, mitoticrate, etc. Theyarethusvulnerabletobe-
ingcriticizedasunrealistic. Moolgavkarhasrecendypublished
aseriesofpapersdescribingincreasinglylessapproximatesolu-
tions to the general model. The latest ofthese gives an exact,
thoughverycomplex, solutionandanapplicationtoradiation-
induced cancer data (16). In principle, these sets ofequations
shouldyieldreliableestimatesofthehazardfunctionbelowthe
observablerange, sincetheirbiologicalbaseisthebestknown.
Inpractice,thesuccessfluseoftheseequationsforthispurpose
willbe sometimeinthefuturebecausetheir solutionrequires
datanotgnerallyaailable,andtheeffectsofvariousapproxima-
tions anddefault parameters have not yet been adequately ex-
plored. Nevertheless, this development is one ofthe most ex-
citing in riskassessment in recentyears.
The authorvery muchapeciates the continued guidancegivenby Suresh
MoolcvkarandalsothestimulagdiscussionswithChrisoph Pbrtieronthis
topic.
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